Assay and Properties of Serum Inhibitor of C'1-Esterase
- 1 August 1959
- journal article
- research article
- Published by Frontiers Media SA in Experimental Biology and Medicine
- Vol. 101 (4) , 608-611
- https://doi.org/10.3181/00379727-101-25034
Abstract
An assay is described for measurement of a serum inhibitor of an esterase derived from preparations of the first component of complement (C[image] 1-esterase). Esterolysis of N-acetyl-L-tyrosine ethyl ester by C[image] 1-esterase is inhibited instantaneously and stoichiometrically by fresh human serum. Units of C[image] 1-esterase and of serum inhibitor are defined. The inhibitor in human serum is stable at -45[degree] for at least 4 months, at 37[degree] for at least 24 hr., and at 48[degree] for at least 30 min. It is completely inactivated during 30 min. incubation at 60[degree] and is labile at 0[degree] at pH values below 6. The inhibitor is inactivated at -5[degree] in the presence of methanol concentrations of 15% or greater but is recovered quantitatively in a 40% (NH4)2 SO4 supernatant fraction. .These data are being applied to purification of the inhibitor from human serum. Purification procedures and properties of the purified inhibitor will be reported elsewhere. Monkey and guinea pig sera inhibit human C[image] 1-esterase to about the same extent as human serum, while rabbit serum is about 1/3 as active. No marked species specificity exists in the interaction of inhibitor in human or rabbit serum with human or rabbit C[image] 1-esterase. These observations are being employed in investigation of the possible role of inhibitor in experimental hypersensitivity.Keywords
This publication has 9 references indexed in Scilit:
- STUDIES ON THE ACTIVATION OF A PROESTERASE ASSOCIATED WITH PARTIALLY PURIFIED FIRST COMPONENT OF HUMAN COMPLEMENTThe Journal of Experimental Medicine, 1958
- SOME PROPERTIES OF AN ESTERASE DERIVED FROM PREPARATIONS OF THE FIRST COMPONENT OF COMPLEMENTThe Journal of Experimental Medicine, 1957
- Observations on a Pro-esterase Associated with Partially Purified First Component of Human Complement (C'1).Experimental Biology and Medicine, 1956
- Elution of an Esterase from Antigen-Antibody Aggregates Treated with Human Complement.Experimental Biology and Medicine, 1956
- CONCERNING THE MECHANISM OF COMPLEMENT ACTION .1. INHIBITION OF COMPLEMENT ACTIVITY BY DIISOPROPYL FLUOPHOSPHATE1956
- CONCERNING THE MECHANISM OF COMPLEMENT ACTION .2. THE NATURE OF THE 1ST COMPONENT OF GUINEA PIG COMPLEMENT1956
- STUDIES ON THE MECHANISM OF INACTIVATION OF HUMAN COMPLEMENT BY PLASMIN AND BY ANTIGEN-ANTIBODY AGGREGATES .2. DEMONSTRATION OF 2 DISTINCT REACTION STAGES IN COMPLEMENT FIXATION1955
- STUDIES ON THE MECHANISM OF INACTIVATION OF HUMAN COMPLEMENT BY PLASMIN AND BY ANTIGEN-ANTIBODY AGGREGATES .1. THE REQUIREMENT FOR A FACTOR RESEMBLING C'1 AND THE ROLE OF CA++1954
- Preparation and Properties of Serum and Plasma Proteins. IV. A System for the Separation into Fractions of the Protein and Lipoprotein Components of Biological Tissues and Fluids1a,b,c,dJournal of the American Chemical Society, 1946